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Abstract
Background: Duplications of MECP2 gene in males cause a syndrome characterized by distinctive clinical
features, including severe to profound mental retardation, infantile hypotonia, mild dysmorphic features, poor
speech development, autistic features, seizures, progressive spasticity and recurrent infections. Patients with
complex chromosome rearrangements, leading to Xq28 duplication, share most of the clinical features of
individuals with tandem duplications, in particular neurologic problems, suggesting a major pathogenetic role of
MECP2 overexpression.
Results: We performed cytogenetic and molecular cytogenetic studies in a previously described family with
affected males showing congenital ataxia, late-onset progressive myoclonic encephalopathy and selective
macular degeneration. Microsatellite, FISH and array-CGH analyses identified a recombinant X chromosome with
a deletion of the PAR1 region, encompassing SHOX, replaced by a duplicated segment of the Xq28 terminal
portion, including MECP2.
Conclusions: Our report describes the identification of the actual genetic cause underlying a severe syndrome
that previous preliminary analyses erroneously associated to a terminal Xp22.33 region. In the present family as
well as in previously reported patients with similar rearrangements, the observed neurologic phenotype is
ascribable to MECP2 duplication, with an undefined contribution of the other involved genes. Maculopathy,
presented by affected males reported here, could be a novel clinical feature associated to Xq28 disomy due to
recombinant X chromosomes, but at present the underlying pathogenetic mechanism is unknown and this
potential clinical correlation should be confirmed through the collection of additional patients.
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Introduction
Large duplications of the X chromosome long arm are
rare, usually involve the distal Xq27-qter region, and
cause a severe phenotype in males, while most carrier fe-
males are phenotypically normal, as a consequence of a
skewed inactivation of the abnormal chromosome [1, 2].
With the clinical application of array-CGH, Xq28 micro-
duplications, including MECP2 gene, emerged as one of
the most common genomic rearrangements in males
with developmental delay [3].
The majority of MECP2 duplications are intrachromo-
somal and represent non-recurrent events, probably me-
diated by fork stalling and template switching (FoSTeS)
mechanism; more rarely, they can arise from complex
rearrangements, resulting in the translocation of the du-
plicated segment to the short arm of the X chromosome,
to an autosome or to the Y chromosome [4–6].
In 1992, Bertini et al. described a family with a severe X-
linked phenotype characterized by congenital ataxia with
generalized hypotonia, psychomotor retardation, late-
onset progressive myoclonic encephalopathy, selective
macular degeneration and recurrent bronchopulmonary
infections. Three-generations linkage analysis revealed
a candidate disease-associated locus on Xp22.33-pter
region [7, 8].
Here, we describe the genetic studies performed in
the above mentioned affected family that led to the
identification of a recombinant X chromosome (qter- >
Xq28::Xp22.33- > qter) causing the severe clinical pheno-
type observed in affected males.
Case presentation
A detailed clinical description of the family is available
in the paper of Bertini et al. [7].
Males II4, III4, III5, III8 and IV3 (Fig. 1) presented
generalized hypotonia at birth and died in infancy be-
cause of severe gastroenteritis (II4) and bronchopneu-
monia (III4, III5, III8 and IV3).
Affected males IV4 and IV23 survived longer, develop-
ing additional clinical features.
Patient IV4
This patient, born in 1979 from non-consanguineous
parents, presented neonatal generalized hypotonia and
delayed motor development. He could walk with sup-
port at 4 years, had poor language with dysarthric
speech, tonic seizures and recurrent bronchopneumo-
nia. Physical and neurological examinations revealed
growth delay (height < 3rd centile, head circumference
< 3rd centile and weight around the 3rd centile), severe
trunk and limb ataxia, dysmetria, hypoactive deep ten-
don reflexes, stereotyped movements and low response
to external stimuli. In the following years, the clinical
course worsened with the occurrence of frequent
(weekly) intractable seizures and visual, motor and in-
tellectual deterioration leading to blindness, generalized
muscular atrophy and severe hypotonia, with frequent
segmental myoclonic jerks. Fundoscopy and brain CT-
scan documented bilateral macular degeneration and
hypoplasia of the cerebellar vermis and corpus callo-
sum, with persistence of cavum vergae, respectively.
Lysosomal diseases, lipofuscinosis, organic acidurias,
aminoacidopathies, biotidinase deficiency and endocrine
disorders were excluded by laboratory examinations.
Ultrastructural analyses of skin and muscle biopsies did
not reveal significant alterations. High resolution
karyotype was normal.
Patient IV23
This patient, born in 1979 from non-consanguineous par-
ents, showed moderate generalized hypotonia at birth, de-
layed psychomotor development, acquiring an unaided but
unsteady gait at 4 years, and impaired speech. Since the
first years of life, the patient suffered from recurrent
bronchopulmonary infections. His neurological condition
was similar to that of patient IV4, with generalized hypo-
tonia, trunk and limb ataxia, dysmetria and hypoactive
deep tendon reflexes. A few years later, drug-resistant
seizures appeared and the ability to walk was lost, with
a severe degeneration of cognitive functions. Brain CT-
scan and MRI showed persistence of the cavum vergae,
hypoplasia of cerebellar vermis and corpus callosum.
Fundoscopy revealed bilateral macular degeneration.
Cytogenetic studies with high resolution banding re-
vealed a normal karyotype.
Affected males’ mothers (III1 and III10) appeared




As suggested by Des Portes et al. [8], who identified the
disease locus (Xp22.33) in the present family, we analysed
additional microsatellite markers mapping within the
PAR1 to confirm linkage results, thus detecting a deletion
Fig. 1 Family pedigree. Affected males (filled symbols) and females
carrying the recombinant X chromosome (circles with dots) are
reported. Family members studied through microsatellite analysis are
indicated by an asterisk
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in obligate carrier females (III1 and III10), III3, III7, IV2
and IV15 (data not shown).
XCI analysis revealed a skewed inactivation of X
chromosome in the peripheral blood cells of all carrier
females, with ratios of peak areas ranging from 97:3 to
85:15.
FISH and array-CGH analyses
FISH analysis with XpYp subtelomere specific probes
confirmed the microdeletion in the tip of chromosome
X short arm (Fig. 2a) in all studied samples (III1, III3,
III7, III10, IV2 and IV15). As the loss of PAR1 did not
explain the neurologic phenotype observed in males, the
DNA of carrier female IV2 was analysed by array-CGH
to evaluate the presence of additional cryptic imbalances
involving different genomic regions. Since both PAR re-
gions were not covered by oligonucleotides in the micro-
array platform used, we were not able to see the deletion
in Xp, but a terminal duplication in Xq28 was detected,
encompassing nearly 3.3 Mb (chrX:151,532,990–
154,841,455) and 130 genes, including MECP2 (Fig. 3).
Additional FISH experiments were performed to de-
fine more precisely the breakpoints of the deletion in Xp
and to determine the localization of the Xq duplicated
segment. BAC, PAC and fosmid clones specific for PAR1
mapped the deletion breakpoint in a ~50 kb region in
Xp22.33, between clones G248P87136C11 (1,097,568–
1,134,076) and WI2 82904A1 (1,184,114–1,227,822)
(Table 1). The deleted segment was therefore entirely lo-
cated within the PAR1 region, extending about 1.2 Mb
and containing five RefSeq genes (PLCXD1, GTPBP6,
LINC00685, PPP2R3B and SHOX).
Finally, a FISH experiment carried out by using an Xq
subtelomeric probe showed that the Xq28 duplicated
segment was translocated to the terminal p-arm region
replacing the deleted portion (Fig. 2b).
Discussion
In this study, cytogenetic and molecular cytogenetic ana-
lyses performed on the family previously described by
Bertini et al. [7] revealed the presence of a recombinant
X chromosome segregating with the disease trait.
Microsatellite markers analysis and FISH studies de-
tected a 1.2 Mb terminal deletion of the short arm of
chromosome X, including SHOX. The haploinsufficiency
of this gene, which escapes lyonization, causes X-linked
idiopathic short stature (MIM 300582) in Turner syn-
drome and Leri-Weill dyschondrosteosis (autosomal
dominant; MIM 127300) whereas mutations of both al-
leles give rise to Langer mesomelic dysplasia (MIM
249700). These syndromes are characterized essentially
by short stature and skeletal defects without neurological
implications. Therefore, the SHOX gene deletion may be
the cause of the Madelung deformity observed in carrier
females, but the severe neurologic phenotype affecting
males of this family is likely due to the Xq28 duplication
identified through array-CGH analysis.
The 3.3 Mb duplicated segment encompasses MECP2
gene, whose duplications are known to cause a defined
syndrome with cardinal features that include early in-
fantile hypotonia, delayed psychomotor development
leading to severe to profound ID with absent to very
limited speech and neurological symptoms (abnormal
gait, epilepsy and spasticity) [9]. In addition, recurrent
infections, especially of the respiratory tract, gastrointes-
tinal motility problems and structural brain anomalies (in
patients who underwent brain imaging) are frequently
recorded.
Although duplications reported in the medical literature
have variable sizes and include additional genes, neuro-
logical defects are mainly ascribed to dosage alteration of
MECP2. Mice overexpressing this gene develop key
neurological features of MECP2 duplication syndrome
Fig. 2 FISH analysis with Xp/Xq subtelomeric probes on peripheral blood metaphases of female IV2. Panel A shows the Xp deletion, with the red
arrow indicating the region where the signal probe is absent. Panel B shows the recombinant X chromosome with two Xq probe signals. The X
chromosome centromere is marked with a specific aqua alphoid DNA probe
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[10, 11]. Moreover, the minimal duplicated region de-
scribed to date in affected males involves exclusively
MECP2 and IRAK1 and is sufficient to cause the core
phenotype [12]. In addition, also in patients with chromo-
somal rearrangements leading to Xq28 functional disomy,
clinical features are consistent with those ofMECP2 dupli-
cation syndrome, supporting further a major role of this
gene in the manifestation of the disease [13]. Recently, the
overexpression of GDI1 and RAB39B has been proposed
to cause cognitive impairment in patients carrying two
different recurrent Xq28 duplications not involving
MECP2, but this milder phenotype implies a modest con-
tribution of dosage alterations of these genes to the severe
clinical manifestations of MECP2 duplication syndrome
due to large aberrations [14, 15].
In the present family, all affected males showed gener-
alized hypotonia since birth; those who deceased at
younger age died of severe gastroenteritis (II4) and bron-
chopneumonia (III4, III5, III8 and IV3). The two elder
patients (IV4 and IV23), in addition to congenital hypo-
tonia and recurrent infections, presented other features
ascribable to MECP2 duplication syndrome, such as
motor and mental deterioration with development of
unsteady gait and impaired speech that were completely
lost at 9 to 10 years, ataxia, seizures and hypoplasia of
the cerebellar vermis and corpus callosum. Macular de-
generation is an important additional clinical feature
observed in the present family, but it has never been
described in patients with MECP2 duplications or re-
combinant X chromosomes involving more extended
regions on both arms [6, 13].
Excluding a missed diagnosis of maculopathy in pub-
lished cases, these findings would suggest that genes map-
ping within the rearranged portions of the X chromosome
Fig. 3 Xq28 duplication identified by array-CGH analysis. The duplicated region is circled on the X chromosome ideogram and the RefSeq genes
involved are reported under the array-CGH profile
Table 1 List of FISH clones used to redefine the Xp deletion.
Genomic position of probes is reported according to the February
2009 human reference sequence (GRCh37/hg19) and the
presence or the absence of the corresponding signals on the
normal and recombinant X chromosomes are indicated by +
and − signs, respectively
Clone Position bp (hg19) X chromosome X derivative
RP13 167H21 803878–917875 + –
RP11 309 M23 915876–1047557 + –
WI2 87136C11 1097568–1134076 + –
WI2 829094A1 1184114–1227822 + +
RP4 674 K6 1347892–1430773 + +
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are not responsible for macular degeneration. However,
maculopathy was reported in some families with X-linked
blue cone monochromacy (MIM 303733) caused by dele-
tions within the opsin genes locus in Xq28 [16–19], sug-
gesting that dosage alterations of these genes could play a
role in macular atrophy through an unknown mechanism
that would need additional genetic or environmental fac-
tors to occur. In the present family, the expression of
opsin genes (or other genes with a potential role in struc-
tural and functional integrity of the macula), included in
the duplicated region, could be altered not only by the
presence of extra copies but also by a positional effect due
to their translocation on Xp. It is difficult to establish
whether in other published cases carrying recombinant X
chromosome the Xq28 duplicated segment was inserted
exactly in the same locus we detected in Xp22.33, because
they were identified through low resolution techniques
and breakpoints were not defined further [20, 21].
Nevertheless, we cannot exclude the involvement of
genes mapping outside the aberration, but still on the
rearranged X chromosome. Indeed, the maculopathy has
been ascertained in the two elder affected males, who
are second degree maternal cousins and could have
inherited the trait exclusively by their healthy mothers,
suggesting an X-linked transmission as for the rest of
the phenotype. However, the hypothesis of an additional
gene alteration independent from the rearrangement is
unlikely. Indeed, it should have segregated and caused
uniquely macular degeneration in at least one of the
eight healthy males of the family, unless the physiologic
meiotic recombination between the two homologues in
carrier females was hampered by the altered structure of
the recombinant X chromosome.
Females with Xq28 duplications are usually asymptom-
atic because of an extreme or complete skewed inactiva-
tion of the rearranged chromosome. Nevertheless, a
clinical phenotype similar to males has been described in
females when the duplicated region remains functionally
active due to its translocation to an autosome [9]. In the
present family, carrier mothers had a skewed X chromo-
some inactivation and presented only mild skeletal anom-
alies of the upper limbs ascribable to the deletion of the
PAR1 region, which escapes lyonization.
Recombinant X chromosomes can arise through two
possible mechanisms. When the breakpoints are flanked
by repeated sequences, an intramolecular recombination
between them could occur during spermatogenesis [22].
Otherwise, the rearrangement could be generated by a
recombination event between an X chromosome with a
pericentric inversion and the normal homolog during fe-
male meiosis [6, 23]. In this family, we defined the
breakpoints through FISH and array-CGH analyses and
homologous repeated sequences were not present in
these regions, making the pericentric inversion the most
likely promoting mechanism. Unfortunately, we could
not verify this hypothesis because all affected males
inherited the delXp/dupXq aberration from their
mothers and the first generation was not available.
Conclusions
This study identifies the Xq28 duplication as the actual
cause of the syndrome presented by the family de-
scribed by Bertini et al. [7] and previously linked to
Xp22.33-pter region by des Portes et al. [8]. Moreover,
the overlap of neurologic features observed in the pre-
sented family with the core phenotype of Xq28 duplica-
tion syndrome is in line with previous suggestions of a
major pathogenetic role of MECP2 dosage alteration.
Finally, additional cases are needed to evaluate a pos-
sible clinical association between MECP2 duplication
syndrome and macular degeneration, whose pathogen-
esis in the reported family is still unclear.
Materials and methods
Molecular analyses
Four microsatellite markers (DXYS28, DXY233, DXYS228,
DXYS230) mapping within the pseudoautosomal region 1
(PAR1), not completely covered in the previously pub-
lished linkage analysis [8], were analysed in 12 family
members (Fig. 1).
DNA was extracted from blood samples using
QIAamp DNA Mini Kit (Qiagen). Microsatellite
markers were amplified by standard PCR protocols
with 5′ fluorescent labeled primers. PCR products
were run on an ABI prism 3730 sequencer (Applied
Biosystems) and peak size was analysed using Gene-
Mapper software (Applied Biosystems).
X-chromosome inactivation (XCI) study was per-
formed on IV2 and on carrier females III1, III3 and
III10, using a modified standard method [24].
Fluorescence In Situ Hybridization (FISH) analysis
FISH analysis was performed on peripheral blood samples
using subtelomere specific probes for both arms of the X
chromosome (XpYp, clone 839D20, locus DXYS129 and
XqYq, clone C8.2/1, locus DXYS61, Cytocell™ Technolo-
gies Ltd; TelVision™ XpYp, locus DXYS129 and XqYq,
EST Cdy 16c07 GenBankZ43206, Vysis Abbott Laborator-
ies), human genomic clones from RPCI BAC and PAC
clones Libraries (RP13-167H21, RP11-309M3 and RP4-
674K6) kindly supplied by Resources for Molecular Cyto-
genetics, University of Bari (Bari, Italy), and human female
clones from the WIBR2 Fosmid Library (WI2 82904A1
and G248P87136C11) obtained from The Wellcome Trust
Sanger Institute (Cambridge, UK). Subtelomeres probes
were hybridized following manufacturers’ instructions.
Bacterial cultures and DNA isolation for BAC/PAC and
fosmid clones were performed according to the BAC/PAC
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miniprep protocol from the Resources for Molecular
Cytogenetics University of Bari website and to Wellcome
Trust Sanger Institute suggested protocols respectively.
Probes were labelled with Biotin-16-dUTP (Roche) by
nick translation, FISH procedures performed according
to a standard protocol and probes detected with FITC-
Streptavidin (Vector).
Slides were analysed on a Zeiss Axioplan 2 (Carl Zeiss,
Göttingen, Germany) epifluorescence microscope and
image analysis was performed on an IKAROS karyotyping
and an ISIS FISH image analysis workstation (Metasys-
tems, Altlussheim, Germany).
Array Comparative Genomic Hybridization (Array CGH)
analysis
The DNA of female IV2 was analysed by array-CGH
through an Agilent 44K platform (Agilent Technologies),
with a mean resolution of about 75 Kb, following manu-
facturer’s instructions. A graphical visualization of the re-
sults was provided by the Genomic Workbench software
v.7.0 and aberrations were called by the ADM1 algorithm
with a sensitivity threshold of 6.0. Genomic position of
alterations was reported according to the February
2009 human reference sequence (GRCh37/hg19).
Consent
Written informed consent was obtained from the patient
for publication of this Case report. A copy of the written
consent is available.
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